v3.26.3
Significant accounting policies (Details Narrative) - USD ($)
 1 Months Ended 6 Months Ended
May 31, 2026
Jul. 31, 2026
Jan. 31, 2026
Subsidiary, Sale of Stock [Line Items]      
Cash   $ 545,960 $ 100,000
Cash equivalents  
Federal depository insurance coverage   250,000  
Investments held in the Trust Account   106,372,992 $ 0
Offering costs $ 5,000,995 5,000,995  
Cash underwriting fee 472,500 472,500  
Deferred underwriting fee 3,675,000 3,675,000  
Legal and other expenses $ 853,495 $ 853,495  
Ordinary stock, shares issued [2]   3,001,250 [1] 2,875,000
Ordinary stock, shares outstanding [2]   3,001,250 [1] 2,875,000
Over-Allotment Option [Member]      
Subsidiary, Sale of Stock [Line Items]      
Subject mandatory redemption   10,500,000  
Public Rights [Member]      
Subsidiary, Sale of Stock [Line Items]      
Ordinary stock, shares issued   10,500,000  
Ordinary stock, shares outstanding   10,500,000  
Private Rights [Member]      
Subsidiary, Sale of Stock [Line Items]      
Ordinary stock, shares issued   226,250  
Ordinary stock, shares outstanding   226,250  
[1] As a result of the partial exercise of the underwriters’ over-allotment option to purchase 500,000 Units, which closed on May 27, 2026, 125,000 of the 375,000 Founder Shares were no longer subject to forfeiture. The remaining 250,000 Founder Shares were forfeited for no consideration upon expiration of the unexercised portion of the over-allotment option in June 2026.
[2] Ordinary shares have been retroactively restated to reflect the issuance of an additional 1,150,000 Founder Shares to the Sponsor for no consideration on February 20, 2026, resulting in an aggregate of 2,875,000 Founder Shares held by the Sponsor (of which 1,725,000 Founder Shares were originally issued on September 29, 2025 for an aggregate purchase price of $25,000), including an aggregate of up to 375,000 Founder Shares that were subject to forfeiture to the extent the underwriters’ Over-Allotment Option was not exercised in full or in part (see Note 5).